Modified fractionation in the radical treatment of non-small-cell lung cancer

Frontiers of Radiation Therapy and Oncology

Volumn 34, Issue , 2000, Pages 80-88

  Baumann, Michael ^a   Appold, Steffen ^a   Zips, Daniel ^a   Nestle, Ursula ^b   Petersen, Cordula ^a   Herrmann, Thomas ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0002870022     PISSN: 00719676     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000061264     Document Type: Article

References (44)

1. Sause WT, Turrisi AT: Principles and application of preoperative and standard radiotherapy for regionally advanced non-small lung cancer; in Pass I (ed): Lung Cancer: Principles and Practice. Philadelphia, Lippincott-Raven, 1996, pp 697-710.
2. Perez CA, Stanley K, Rubin P, Kramer S, Brady LW, Perez-Tamayo R, Brown GS, Concannon J, Rotman M, Seydel HG: A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung: Preliminary report by the Radiation Therapy Oncology Group. Cancer 1980;45:2744-2753.
3. Dillman RO, Seagren SL, Herndon J, Propert KJ, Guerra J, Eaton WL, Perry MC, Carey RW, Frei EF, Green MR: A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small cell lung cancer. N Engl J Med 1990;323:940-945.
4. Sause WT, Scott C, Taylor S, Johnson D, Livingston R, Komaki R, Emami B, Curran WJ, Byhardt RW, Turrisi AT, Dar AR, Cox JD: Radiation therapy oncology group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer. J Natl Cancer Inst 1995;87:198-205.
5. Perez CA, Pajak TF, Rubin P, Simpson JR, Mohiuddin M, Brady LW, Perez-Tamayo R, Rotman M: Long-term observations of the pattern of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group. Cancer 1987;59:1874-1881.
6. Arriagada R, Le Chevalier T, Quoix E, Ruffie P, De Cremoux H, Douillard JY, Tarayre M, Pignon JP, Laplanche A for the GETCB, the FNCLCC and the CEBI trialists: ASTRO Plenary: Effect of chemotherapy on locally advanced non-small cell lung carcinoma: A randomized study of 353 patients. Int J Radiat Oncol Biol Phys 1991;20:1183-1190.
7. Saunders M, Dische S, Barrett A, Harvey A, Griffiths G, Parmar M (on behalf of the CHART steering committee): Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: Mature data from the randomised multicentre trial. Radiother Oncol 1999;52:137-148.
8. Schultz-Hector S: Heart; in Scherer E, Streffer C, Trott KR (eds): Radiopathology of Organs and Tissues. Berlin, Springer, 1991, pp 347-368.
9. Travis EL: Lung morbidity of radiotherapy; in Plowman PN, McElwain T, Meadows A (eds): Complications of Cancer Management. Oxford, Butterworths-Heinemann, 1991, pp 232-249.
10. Baumann M, Liertz C, Baisch H, Wiegel T, Lorenzen J, Arps H: Impact of overall treatment time of fractionated irradiation on local control of human FaDu squamous cell carcinoma in nude mice. Radiother Oncol 1994;32:137-143.
11. McDonald S, Rubin P, Phillips T, Marks L: Injury to the lung from cancer therapy: Clinical syndromes, measurable endpoints, and potential scoring systems. Int J Radiat Oncol Biol Phys 1995;31:1187-1203.
12. Herrmann T, Knorr A: Die radiogene Lungenreaktion. Strahlenther Onkol 1995;171:490-498.
13. Steel GG (ed): Basic Clinical Radiobiology, ed 2. London, Arnold, 1997.
14. Petersen C, Baumann M, Dubben HH, Arps H, Melenkeit A, Helfrich J: Linear-quadratic analysis of tumour response to fractionated radiotherapy: A study on human squamous cell carcinoma xenografts. Int J Radiat Biol 1998;73:197-205.
15. Withers HR, Taylor JMG, Maciejewski B: The hazard of accelerated tumor clonogen repopulation. Acta Oncol 1988;27:131-146.
16. Dische S, Saunders M, Barrett A, Harvey A, Gibson D, Parmar M: A randomized multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol 1997;44:123-136.
17. Fu KK, Pajak TF, Trotti A, Spencer SA, Jones CU, Phillips TL, Garden AS, Ridge JA, Cooper JS, Ang, KK: A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: Preliminary results of RTOG 9003 (abstract). Int J Radiat Oncol Biol Phys 1999;45:145.
18. Horiot JC, Bontemps P, Van den Bogart W, Le Fur R, Van den Weijngaert D, Bolla M, Bernier J, Lusinchi A, Stuschke M, Lopez-Torrecilla J, Begg AC, Pierart M, Collette L: Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: Results of the EORTC 22581 randomized trial. Radiother Oncol 1997;44:111-112.
19. Overgaard J, Sand Hansen H, Sapru W, Overgaard M, Grau C, Jorgensen KE, Bastholt L, Hansen O, Spechtl L, Berthelsen A: Conventional radiotherapy as the primary treatment of squamous cell carcinoma (SCC) of the head and neck. A randomized multicenter study of 5 versus 6 fractions per week - Preliminary report from the DAHANCA 6 and 7 trial (abstract). Radiother Oncol 1996;40:31.
20. Baumann M, Petersen C, Schulz P, Baisch H: Impact of overall treatment time on local control of slow growing human GL squamous cell carcinoma in nude mice treated by fractionated irradiation. Radiother Oncol 1999;50:107-111.
21. Baumann M, Budach V, Appold S: Strahlentoleranz des menschlichen Rückenmarks. Strahlenther Onkol 1994;170:131-139.
22. Saunders M, Dische S, Barrett A, Harvey A, Gibson D, Parmar M: Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: A randomised multicentre trial. Lancet 1997;350:161-165.
23. Dörr W: Three A's of normal tissue repopulation: A review of mechanisms. Int J Radiat Biol 1997;72:635-644.
24. Bentzen SM, Skoczylas JZ, Bernier J: Quantitative clinical radiobiology of early and late lung reactions. Int J Radiat Biol, in press.
25. Thames HD, Peters LJ, Withers HR, Fletcher GH: Accelerated fractionation vs hyperfractionation: Rationales for several treatments per day. Int J Radiat Oncol Biol Phys 1983;9:127-138.
26. Withers HR: Biological basis for altered fractionation schedules. Cancer 1985;55:2086-2095.
27. Bentzen SM: Quantitative clinical radiobiology. Acta Oncol 1993;32:259-275.
28. Beck-Bornholdt HP, Omniczynski M, Theis E, Vogler H, Würschmidt F: Influence of treatment time on the response of rat rhabdomyosarcoma R1H to fractionated irradiation. Acta Oncol 1991;30:57-63.
29. Petersen C, Baumann M: Mechanismen des Zeitfaktors in der Onkologie. Strahlenther Onkol, in press.
30. Cox JD, Azarnia N, Byhardt RW, Shin KH, Emami B, Pajak TF: A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: Possible survival benefit with ≥69.6 Gy in favourable patients with radiation therapy oncology group stage III non-small-cell lung carcinoma: Report of radiation therapy oncology group 83-11. J Clin Oncol 1990;8:1543-1555.
31. Beck-Bornholdt H-P, Dubben H-H, Liertz-Petersen C, Willers H: Hyperfractionation: Where do we stand? Radiother Oncol 1997;43:1-21.
32. Komaki R, Scott C, Sause W, Johnson DH, Taylor SG, Lee JS, Emami B, Byhardt RW, Curran WJ, Dar AR, Cox JD: Induction cisplatin/vinblastine and irradiation vs irradiation in unresectable squamous-cell lung cancer: Failure patterns by cell type in RTOG 88-08/ECOG 4588. Int J Radiat Oncol Biol Phys 1997;39:537-544.
33. Ball D, Bishop J, Smith J, O'Brien P, Davis S, Ryan G, Olver I, Toner G, Walker Q, Joseph D: A randomized phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: Final report of an Australian multi-centre trial. Radiother Oncol 1999;52:129-136.
34. Baumann M: Accelerated radiation therapy in non-small cell lung cancer. Radiother Oncol 1999;52:97-99.
35. Liao ZX, Travis EL, Tucker SL: Damage and morbidity from pneumonitis after irradiation of partial volumes of mouse lung. Int J Radiat Oncol Biol Phys 1995;32:1359-1370.
36. Herrmann T, Baumann M, Voigtmann L, Knorr A: Effect of irradiated volume on lung damage in pigs. Radiother Oncol 1997;44:35-40.
37. Marks LB, Munley MT, Spencer DP, Sherhouse GW, Bentel GC, Hoppenworth J, Chew M, Jasczak RJ, Coleman RE, Prosnitz LR: Quantification of radiation-induced regional lung injury with perfusion imaging. Int J Radiat Oncol Biol Phys 1997;38:399-409.
38. Theuws JCM, Kwa SLS, Wagenaar AC, Boersma LJ, Damen EMF, Muller SH, Baas P, Lebesque IV: Dose-effect relations for early local pulmonary injury after irradiation for malignant lymphoma and breast cancer. Radiother Oncol 1998;48:33-43.
39. Baumann M, Appold S, Geyer P, Knorr A, Voigtmann L, Herrmann T: Lack of effect of small high dose volumes on the dose-response relationship for the development of fibrosis in distant parts of the ipsilateral lung in mini-pigs. Int J Radiat Biol, in press.
40. Armstrong JG: Target volume definition for three-dimensional conformal radiation therapy on lung cancer. Br J Radiol 1998;71:587-594.
41. Armstrong JG: Radiation pneumonitis: The impact of dose escalation with conformal radiotherapy. Int J Radiat Biol, in press.
42. Armstrong JG, Raben A, Zelefsky M, Burt M, Leibel S, Burman C, Kutcher G, Harrisson L, Hahn C, Ginsberg R, Rusch V, Kris M, Fuks Z: Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer. Radiother Oncol 1998;44:17-22.
43. Baumann M, Herrmann T, Matthiesen W, Koch R, Strelocke K, Paul U: CHARTWEL-Bronchus (ARO 97-1) Eine randomisiert multizentrische Studie zum Vergleich einer konventionell fraktionierten Strahlentherapie mit CHARTWEL-Bestrahlung bei inoperablen nichtkleinzelligen Bronchialkarzinomen. Strahlenther Onkol 1997;173:663-667.
44. Saunders M, Rojas A, Lyn BE, Pigott K, Powell M, Goodchild K, Hoskin PJ, Philips M, Verma N: Experience with dose escalation using CHARTWEL (continuous hyperfractionated accelerated radiotherapy weekend less) in non-small-cell lung cancer. Br J Cancer 1998;78:1323-1328.